Related Experiment Videos
Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003
Sandra S Richter1, Kristopher P Heilmann, Susan E Beekmann
1Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, IA 52242-1009, USA. sandra-richter@uiowa.edu
Background:
Increased levels of macrolide-resistant Streptococcus pyogenes in focal regions of the United States have been reported. The purpose of this study was to determine the antimicrobial susceptibility of a large collection of S. pyogenes isolates from throughout the United States and to elucidate the mechanisms of resistance and genetic relatedness of macrolide-resistant isolates.
Methods:
During 2002-2003, a total of 1885 S. pyogenes clinical isolates were obtained from 45 US medical centers. Susceptibility to penicillin, cefdinir, erythromycin, azithromycin, clarithromycin, clindamycin, telithromycin, and levofloxacin was determined. Macrolide resistance phenotypes were determined by double-disk diffusion, and macrolide resistance genotypes were determined by polymerase chain reaction and sequencing. All macrolide-resistant isolates and all isolates recovered from sterile sites were further characterized by pulsed-field gel electrophoresis (PFGE) and emm typing.
Results:
The majority (85%) of isolates were pharyngeal. Resistance was detected to erythromycin (6.8% of isolates), azithromycin (6.9%), clarithromycin (6.6%), clindamycin (0.5%), telithromycin (0.2%), and levofloxacin (0.05%). The macrolide-resistance phenotype distribution was as follows: macrolide-lincosamide-streptogramin B (MLSB), 56% of isolates (inducible, 47%; constitutive, 9%); and M, 44%. The genotypes detected were as follows: ermA, 46% of isolates (95% with inducible MLSB phenotype); mefA, 43% (all with M phenotype); and ermB, 8.5% (45% with inducible MLSB and 45% with constitutive MLSB). Three isolates with constitutive MLSB phenotypes had 23S ribosomal RNA mutations. The 129 erythromycin-resistant isolates belonged to 28 emm types and 44 PFGE patterns, with 51% of the isolates in 4 major PFGE clones each associated with a predominant emm type (emm75, emm58, emm12, and emm114) and resistance genotype (mefA or ermA)).
Conclusions:
The population of macrolide-resistant S. pyogenes isolates in the United States is small, but it includes several large clones with potential for expansion.
Insights
Macrolide-resistant Streptococcus pyogenes strains are present in the US, with resistance mechanisms including ermA and mefA genes. While the overall population is small, certain clones show potential for expansion, highlighting the need for ongoing surveillance.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Reports indicate rising macrolide-resistant Streptococcus pyogenes in the US.
- Understanding resistance mechanisms and genetic relatedness is crucial for public health.
Purpose of the Study:
- To determine antimicrobial susceptibility of S. pyogenes isolates nationwide.
- To identify mechanisms and genetic links among macrolide-resistant strains.
Main Methods:
- Analyzed 1885 S. pyogenes isolates from 45 US centers (2002-2003).
- Assessed susceptibility to various antibiotics.
- Determined macrolide resistance phenotypes and genotypes (PCR, sequencing).
- Characterized resistant isolates using PFGE and emm typing.
Main Results:
- Resistance detected to erythromycin (6.8%), azithromycin (6.9%), and clarithromycin (6.6%).
- Macrolide resistance phenotypes were MLSB (56%) and M (44%).
- Genotypes ermA and mefA were prevalent, linked to specific resistance phenotypes.
- Erythromycin-resistant isolates clustered into major clones associated with specific emm types and resistance genes.
Conclusions:
- The population of macrolide-resistant S. pyogenes in the US is currently small.
- However, several large clones exist with the potential for future expansion.
Related Concept Videos
Streptococcal Pharyngitis
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Acute Pyelonephritis II: Diagnostic Studies and Management
Atypical Pneumonia
Rocky Mountain Spotted Fever